Peter V. Danenberg

10.8k citations
155 papers · 7.9k · 3 hit papers · h-index 47

Impact in

Papers in

    • Biochemical and Molecular Research 25
    • RNA modifications and cancer 9
    • Colorectal Cancer Treatments and Studies 29
    • Cancer-related Molecular Pathways 11

Peter V. Danenberg

150 papers receiving 7.6k citations

Peter V. Danenberg's Hit Papers

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. 2002 · 550 citations
5500+16+32Years since publication100200300400500

Peers

Peter V. Danenberg
Comparison fields: 5 of 116
  • Oncology 3.2k
  • Cancer Research 1.2k
  • Molecular Biology 3.5k
  • Pathology and Forensic Medicine 759
  • Pulmonary and Respiratory Medicine 1.3k
Replace Kathleen D. Danenberg with:
Kathleen D. Danenberg United States
Masakazu Fukushima Japan
William F. Benedict United States
C C Harris United States
Chris H. Takimoto United States
Martin N. Raber United States
P. V. Danenberg United States
Benjamin Drewinko United States
Dick J. Richel Netherlands
Tetsuro Kubota Japan
Peter V. Danenberg relative to Kathleen D. Danenberg United States Kathleen D. Danenberg's profile →
Citations per field
00.5×1.5×
Kathleen D. Danenberg · 1×
Citations per year

Countries citing papers authored by Peter V. Danenberg

Since Specialization
Citations

This map shows the geographic impact of Peter V. Danenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Danenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Danenberg more than expected).

Fields of papers citing papers by Peter V. Danenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter V. Danenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Danenberg. The network helps show where Peter V. Danenberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter V. Danenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter V. Danenberg Line = papers co-authored together Peter V. Danenberg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.
Hit paper breakdown →
2002550
2
ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy
Hit paper breakdown →
2001512
3
Thymidylate synthetase - a target enzyme in cancer chemotherapy
Hit paper breakdown →
1977445
4 2014310
5
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
2000307
6
Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.
2002255
7 2000199
8
Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
2001192
9
Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin.
1999191
10
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival.
1998179
11 1978152
12 1974152
13 2008125
14 1981121
15 2001114
16 2005113
17
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.
1984111
18 2010106
19 2002101
20 200897

About Peter V. Danenberg

Peter V. Danenberg is a scholar working on Molecular Biology, Oncology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 155 papers that have together received 7.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (29 papers), Biochemical and Molecular Research (25 papers), Esophageal Cancer Research and Treatment (17 papers), Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (11 papers), Cancer-related Molecular Pathways (11 papers), Cancer, Hypoxia, and Metabolism (11 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Oncology (3.2k citations), Cancer Research (1.2k citations), Molecular Biology (3.5k citations), Pathology and Forensic Medicine (759 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Peter V. Danenberg has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Kathleen D. Danenberg, Jan Brabender, Heinz‐Josef Lenz, Reginald V. Lord, Dennis Salonga, Charles Heidelberger, Ralf Metzger, Arnold Lockshin, Susan Groshen and Paul M. Schneider. Their work appears in journals such as Journal of Medicinal Chemistry, Clinical Cancer Research, Biochemistry, Journal of Gastrointestinal Surgery and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact